Skip to main content

Table 2 baseline comparison between mRS 2–6 and mRS 0–1 groups

From: Clinical significance of neutrophil to lymphocyte ratio in ischemic stroke and transient ischemic attack in young adults

 

Overall

N = 691

mRS 2–6

N = 154

mRS 0–1

N = 537

P value

Age, years (median [IQR])

37 [33, 42]

38 [35, 42]

37 [32, 42]

0.03

Male, n (%)

111 (16.06)

20 (12.99)

91 (16.95)

0.24

Admission NIHSS score, (median [IQR])

2 [0, 5]

8 [6, 10]

1 [0, 3]

< 0.001

Thrombolysis, n (%)

31 (4.49)

10 (6.49)

21 (3.91)

0.17

Hypertension, n (%)

324 (46.89)

74 (48.05)

250 (46.55)

0.74

Diabetes, n (%)

121 (17.51)

26 (16.88)

95 (17.69)

0.81

Dyslipidemia, n (%)

91 (13.17)

12 (7.79)

79 (14.71)

0.03

Atrial fibrillation, n (%)

11 (1.59)

6 (3.90)

5 (0.93)

0.03

Prior ischemic stroke, n (%)

74 (10.71)

20 (12.99)

54 (10.06)

0.3

Prior hemorrhagic stroke, n (%)

9 (1.30)

4 (2.60)

5 (0.93)

0.23

Coronary heart disease, n (%)

22 (3.18)

5 (3.25)

17 (3.17)

0.91

Smoking status, n (%)

   

0.02

  Never smoker

302 (43.70)

52 (33.77)

250 (46.55)

 

  Past smoker

22 (3.18)

5 (3.25)

17 (3.17)

 

  Current smoker

367 (53.11)

97 (62.99)

270 (50.28)

 

Alcoholic status, n (%)

   

0.44

  Never drinked

475 (68.74)

100 (64.94)

375 (69.83)

 

  Past drinked

11 (1.59)

2 (1.30)

9 (1.68)

 

  Current drinking

205 (29.67)

52 (33.77)

153 (28.49)

 

Prior antiplatelet agents, n (%)

52 (7.53)

14 (9.09)

38 (7.08)

0.40

Prior anticoagulation agents, n (%)

11 (1.59)

5 (3.25)

6 (1.12)

0.14

Systolic blood pressure, mmHg (median [IQR])

141.00 [129.00, 161.00]

149.00 [129.25, 170.00]

140.00 [129.00, 159.00]

0.01

Diastolic blood pressure, mmHg (median [IQR])

91.00 [81.00, 104.00]

96.00 [82.00, 109.50]

90.00 [81.00, 103.00]

0.01

Triglyceride, mmol/L (median [IQR])

1.42 [1.03, 2.04]

1.38 [1.06, 1.91]

1.43 [1.02, 2.09]

0.68

Cholesterol, mmol/L (median [IQR])

3.74 [3.03, 4.53]

3.94 [3.29, 4.55]

3.66 [3.02, 4.52]

0.09

High density lipoprotein, mmol/L (median [IQR])

0.99 [0.85, 1.16]

0.99 [0.86, 1.13]

1.00 [0.85, 1.17]

0.65

Low density lipoprotein, mmol/L (median [IQR])

2.18 [1.63, 2.90]

2.36 [1.81, 3.00]

2.13 [1.60, 2.87]

0.04

CRP, mg/L (median [IQR])

1.18 [0.49, 3.66]

2.17 [0.90, 7.14]

1.01 [0.43, 2.93]

< 0.001

NLR (median [IQR])

2.60 [1.91, 3.85]

3.38 [2.48, 5.24]

2.39 [1.84, 3.54]

< 0.001

Glucose, mmol/L (median [IQR])

5.50 [4.70, 6.90]

5.92 [5.00, 7.68]

5.46 [4.62, 6.71]

0.01

Pulmonary infection, n (%)

32 (4.63)

17 (11.04)

15 (2.79)

< 0.001

Urinary infection, n (%)

5 (0.72)

1 (0.65)

4 (0.74)

1

Infectious diarrhea, n (%)

5 (0.72)

2 (1.30)

3 (0.56)

0.68

Deep venous thrombosis, n (%)

20 (2.89)

7 (4.55)

13 (2.42)

0.27

Hemorrhagic transformation, n (%)

101 (14.62)

34 (22.08)

67 (12.48)

0.01

TOAST, n (%)

   

0.1

  LAA

314 (45.44)

80 (51.95)

234 (43.58)

 

  CE

46 (6.66)

14 (9.09)

32 (5.96)

 

  SAA

80 (11.58)

15 (9.74)

65 (12.10)

 

  Other

150 (21.71)

30 (19.48)

120 (22.35)

 

  Unknown

101 (14.62)

15 (9.74)

86 (16.01)

 
  1. NLR, neutrophil to lymphocyte ratio; NIHSS, national institutes of health stroke scale; TOAST, Trial of Org 10,172 in Acute Stroke Treatment; LAA, large atherosclerosis artery; CE, cardiac embolism; SAA, small artery occlusion; mRS, modified Rankin Scale